Skip to main content

Advertisement

Table 1 Clinical and biochemical characteristics of all subjects

From: The association between BMP4 gene polymorphism and its serum level with the incidence of LVH in hypertensive patients

Variables LVH+ N = 420 LVH− N = 845 P value
Age (years) 52.5 ± 6.6 51.8 ± 8.4 NS
Male (n, %) 67.5% 68.2% NS
Alcohol intake (n, %) 32.8% 30.5% NS
Smoker (n, %) 46.7% 26.4.1% 0.011
BMI (kg/m2) 24.4 ± 2.2 23.8 ± 3.5 NS
SBP (mmHg) 152.9 ± 8.0 149.6 ± 11.5 NS
DBP (mmHg) 87.8 ± 7.9 89.5 ± 10.6 NS
TG (ng/dl) 5.2 ± 2.8 5.1 ± 2.3 NS
TC (ng/dl) 1.6 ± 0.3 1.6 ± 0.4 NS
HDL-C (ng/dl) 1.3 ± 0.8 1.7 ± 0.5 NS
LDL-C (ng/dl) 2.5 ± 0.8 2.6 ± 0.5 NS
sCr (mmol/l) 101.6 ± 11.5 90.8 ± 12.7 NS
Duration since EH diagnosis (months) 24.4 ± 3.9 23.7 ± 5.2 NS
Therapy protocol    
 ACEI (%) 36.7 35.9 NS
  Time (month) 17.7 ± 3.2 16.8 ± 4.8 NS
 ARB (%) 28.9 28.9 NS
  Time (month) 12.8 ± 2.2 12.4 ± 1.8 NS
 CCB (%) 33.2 32.6 NS
  Time (month) 13.5 ± 3.1 13.4 ± 1.9 NS
 Diuretics (%) 6.8 6.7 NS
  Time (month) 8.7 ± 2.1 8.8 ± 2.6 NS
 β-blocker (%) 23.7 24.1 NS
  Time (month) 16.2 ± 3.0 16.0 ± 2.3 NS
 Others (%) 22.7 21.8 NS
  Time (month) 7.7 ± 1.2 7.8 ± 0.9 NS